production

Bluebird bio Inc

company

$BLUE seriously, how can a company be so bad at execution?

.i hate this fuccccccing company 🖕🏼🖕🏼🖕🏼

Plenty of other companies are mentioned and while we can pick one or two sentences out of the lengthy form that might make you get excited i just do not believe theres anything there indicating a BO or even a partnership.

It’s agonizing as we have not heard a feedback or response from the company regarding it. 1.

$BLUE The overall Market and the delay (NO COMMUNICATION) from the company leads to a substantial decrease in stock value.

Seems like company management hates its own shareholders

$BLUE this company is so defenseless, they don&#39;t even delete the vulgar replies to their tweets.

hand

didnt know there were so many weak hands.

Cash on hand going DOWN daily with no progress toward commercialization.

They use many tactics to scare the money right out of your hands.

but the cash burn compared with cash on hand is concerning.

It means they are worried and with do whatever is necessary to scare weak hands.

loss

Losses creating more losses to recoup other losses lol

$BLUE   Well, lol, beginning with ZERO DOLLARS , this statement is not ROCKET  SCIENCE, lol, yet, yet , earnings will still show a LOSS against revenues !!!

The idea of selling this at a $3,000 loss after sitting on it since July is unacceptable.

Now I am  sitting just about at a loss hope there isn’t much more downside.

$BLUE the stop losses getting triggered today must be frustrating.

$PRVB reported losses and missed revenue target. BOOM.

move

Everything else moves and we just sit in the same spot.

$BLUE   Well well well…..up 300 on the DOW and this pos , is that, a turd.

This pos was $6.50 after they got their first drug approved , lol…Aug 2022..and you are still here at $6.50 !!!!

And so, you have it…a lousy ending to this pos

This pos burnt so many from $100, they changed mgmt and it still hasn’t fixed the problem.

Here to make money, this pos doesn’t deserve to be even listed.

$BLUE  
VERU 
∙ 11/9 Adcom 
∙ High Efficacy (COVID WHO 4/5 pts) 
∙ Excellent Safety traits 
∙ Positive Peer Review completed 
∙ NEJM published  
∙ SI = 25% 
∙ EUA for Sabizabulin = $$$$$$$$$$$$

$BLUE since just starting ramping of 2 approved treatments, eps s/b pretty easy (mostly expenses).

I’m hopeful it’s because they’re extremely confident in love-cel and ramping up the budget for launch next year 🚀

$BLUE agreed, even without a b/o, too much bullish fundamental news and any announcement on further progress on pipeline or ramping up the current 2 approvals should provide fuel for that push through double digits

news

but good news, I am sending Andrew a gift! https://bagofdicks.com/

The silence will break soon with really good news

$BLUE tuff market   But good news around the corner.

$BLUE The most positive news is it’s one day closer to the earnings release and one day closer to the BLA submission plus this is currently a rare day where this is beating out the XBI and LABU by not being down as much.

$BLUE very bullish here and ready for news any moment or day

I would expect some very good news and a turn around to come very soon. 🤞

This is trading like good news is coming! !

potential

Way to maximize the talent pool and help everyone reach their potential BLUE!!

Watching these for potentially more upside continuation next week.

Large potential population of users
6. good/honest management
7.

Sign up today and start receiving expert insights on potential market opportunities 
 
📈FREE trade-of-week via(Google Search) ⟶  𝐟𝐫𝐞𝐞𝐚𝐥𝐞𝐫𝐭.𝐩𝐰

though because there is just  so much potential for BLUE now.

entry

Good entry on friday..ill wait for a 10% profit..amd out, untul next leg.. 🤑🤑🤑

$BLUE almost $4, may be is s good entry point soon.

Attractive entry for the long term potential here.

$BLUE well if there was ever a good entry point it was there today in my opinion

We provide all ENTRIES and EXITS clearly!

We provide all of our ENTRIES and EXITS for the plays, give you the plan and guide you along those plans.

Acelrx Pharmaceuticals Inc

deal

$ACRX so they make a deal (give away the drug for nothing)and don’t have the BBB alls to do a cc to explain.

Main risks would be continued delays or underwhelming deal for DSUVIA, lack of US Army orders, and any delays/setbacks to EUA for NIYAD.

SHIT COMPANY MANAGEMENT  TELLING STORIES ABOUT PARTNERSHIP AND LICENSE DEAL SINCE 2018, BUT NOTHING MATERIALIZED.

NO PARTNERSHIP LICENSING DEALS, SHIT COMPANY MANAGEMENT KEEPS ON TELLING STORIES SINCE 2018.

By them pushing the deal so far back it hints to me that they don’t truly plan to make any money next year as there is no concern for saving money on taxes, either that or there is no upfront or it’s minuscule

But of course, they were silent about the details of such deal.

revenue

Terrible management 
No execution of good drug revenue plan and we all lost our all money here
I lost most here too
I will never invest in bio or drug related stock which requires FDA approval 
All scam and fraud mostly
90% bio.

SHIT COMPANY MANAGEMENT KEEPS ON TELLING STORIES ABOUT PARTNERSHIP SINCE 2018 TILL TO DATE NOTHING MATERIALIZED AND NO REVENUE.

Negative REVENUE (not sure how you do that) reported this morning.

Spending more than revenue is not financial results it&#39;s lack of financial results.

but bad managment you would think with such a good drug they could have done better but vince felt the need to keep paying him and his team ridiculous weekly salarys without any revenues to cover sorry acrx my funds will no longer be kept here.

PFS-01 &amp; 02          
-  &quot;exceeds $100 million&quot;          
-  &quot;Perioperative medication errors.

patient

-  Frequent blood draws to measure calcium  
are time-consuming and expensive 
-   Even more complicated in patients with liver failure

$ACRX  Sad for Lupus patients, which is very painful too!

The flow rates used to clear waste products and remove fluid from the patient are very fast, potentially putting stress on a patient’s heart and blood pressure.

-  Even more complicated in patients with liver failure    
    
Heparin    
-  Significant safety concern for patients at risk of bleeding.

-  Even more complicated in patients with liver failure 
 
Heparin 
-  Significant safety concern for patients at risk of bleeding 
-  Clinicians fear over anticoagulating the patient 
-  Etc.

Prognosis for patients with ARDS is generally poor and varies based on the severity of illness, the precipitating insult, and medical comorbidities.

Any ideas what’s holding them up on saving their clients money and providing their patients the best in class anesthesia?

executive

I fail to find the right words to describe how pathetic this guy is. CEO?

$ACRX 
So I guess HC Wainwright’s has taken the role of CFO and Rafi has taken the role of CEO…..  WTF is goin’ on over there?!

$ACRX 
Never thought that I will lose all my money here
CEO CFO should deserve to be fire

And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA

And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA.

Niydad might be a tasty accretive buy, with EUA likely in 2023, etc.

And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA (Emergency Use Authorization).

quot

$ACRX  
 
12/29/23 - 3rd Qtr ER  
 
&quot;Vincent Angotti: Thank you, Raffi.

Just MAZIMIZE shareholder value, so do it right! &quot;.

$ACRX The FDA will be pleased with AcelRx &quot;growing database supporting the benefits of DSUVIA-DZUVEO!

&quot;We&#39;re excited to now have DZUVEO as part of our product portfolio available to our existing customers.

product

$ACRX AcelRx has some GREAT EMA &amp; FDA approved products, and I like the potential of Niyad!

$ACRX Battlefield Pain Management 
Our new products meet these requirements and add to the pain-treatment options available to care providers.

It allows doctors to give patients the fluids, nutrition, antibiotics and other medications they need without worrying about the accumulation of waste products and fluid from the failing kidneys.

$ACRX here, let me sum it all up:  Dsuvia=great idea, and a good product.

The slow and continuous nature of the process, typically performed over a 24-hour period, allows patients with unstable blood pressure and heart rates, which is termed hemodynamically unstable, to better tolerate this process.

Ocugen Inc

rate

Strange responses for a company with such high turnover rate and ranked #1 place to work at?

next big news: heart attack rates highest ever in march 2023, courtesy of crap admin

OCGN IS on a cash burn rate countdown to zero and no longer has ANY CREDIBILITY with the investment industry.

Ocgn is on cash burn rate countdown to zero. Duh.

Currently 3 cents above 52 week low, on cash burn rate countdown to zero or more Dilution, the dumbest meme stock failure in the history of meme stocks, attracts paid pumpers to tell you that the sky is the limit !!!

The rate of borrowing is f&#39;king ridiculous.

Literally the turnover rate is higher then fast food industry.

interest

Fake news or hype: Scammers may use fake news or hype to generate interest in their stock.

They’ll NEVER make it as traders bc they have no interest in learning and developing their craft.

$OCGN  and still you are here..with no interest whatsover. pathetic

$OCGN Short interest declining steadily since April..

but think they would be perfect for the fda- pretending to have our best interest at heart but just corrupt to the core.

They have no vested interest here ….APPARENTLY!!!!

$OCGN Or muppets with apparently no interest !!!

demoncrats

$OCGN This market is garbage.. Ty Biden voters..

Powell and that other worthless moron sleepy Joe are destroying this company one day at a time.

$OCGN Fck Biden that scum 🪣 bucket is the worst president in history!

$OCGN $ZOM Joe Biden literally the worst think to happen to America since my birth, holy shit.

$OCGN fuck Shankar, fuck Ocugen, fuck FDA, fuck Biden that is all.

Thanks Joe Biden you absolute fucking waste of a president.

Because the Democrats do not care about the middle

Biden&#39;s obviously corrupt and complicit media covering it up.

Nothing about her putting her seal of approval on any OCGN product.

Here you see a paid basher trying to spread misinformation, originating from the vaccine manufacturers themselves, to try to discredit the product our company is developing.

$OCGN OCGN pipeline consists of unwanted, mediocre at best, not financially viable products.

But there is not enough product that&#39;s its a big old NOTHING BURGER terms of sales.

There is no manufacturing or product lot release without a Quality a team.

Nothing says a tech transfer needs a fda approved product that’s beyond idiotic.

Big pharma is evil - our eye, knee, gene modifier products are a threat their evil as well.

Again they failed to bring this product to market and are so late its laughable.

fear

There only joy is fear and literally getting enjoyment of bothering others -like mosquitos - it’s really sad and a mental issue

Fear, and manipulation thrown to neophyte readers.

$OCGN  This poster is bashing and engaged in hate mongering without providing any substantive analysis or documentary evidence to support hisr allegations.

We get government funding- we execute atm funding - NeoCart phase 3 trials and EuA for nasal vaccine for Usa Europe and japan - I feel extra bullish after AstraZeneca fails nasal vaccine trials.

$OCGN Bharat Biotech is a real winner this year 👍🏻👍🏻 
Best production award  
Best COVID Vaccine 😊💪🏻🔥 
https://www.terrapinn.com/conference/world-vaccine-congress-washington/ViE-Awards-2023.stm

This is a big catalyst and immediately opens the open to revenue - Mexico and we might even manufacture for BB to ship to other countries.

Also, Friendly reminder: Our new VP of Manufacturing and Supply, Ranjit- Continues to receive the love on his new role at Ocugen!

$OCGN Our NEW VP of Manufacturing and Supply is an absolute STUD!

This is bullish and a good sign for us, basically showing us that manufacturing is evidently underway and in process for the near future.

$OCGN manufacturing on top of being unbelievable scientist

$OCGN  nice liking the price today okiee https://www.reddit.com/r/shortsqueeze2023/comments/11t3p7v/what_to_expect_for_ocgn_must_read/?utm_source=share&amp;utm_medium=ios_app&amp;utm_name=iossmf

$OCGN OCGN  &amp; PLSH  on cannabinoid research and now the stocks  almost the same share price what a golden opportunity go Ocu400

$OCGN LA is an easy flight for me &amp; my job is remote.

Please may I have some more !!!!!! https://giphy.com/gifs/D3OdaKTGlpTBC?utm_source=media-link&amp;utm_medium=landing&amp;utm_campaign=Media%20Links&amp;utm_term=

$ADXN as a successful former business owner and successful investor, I think that after this company tripling and now expecting epilepsy news, they are 1000% bullish they are going to going to the next phase with Johnson &amp; Johnson.

😎🍺😎
ABSOLUTELY BULLISH™️ https://twitter.com/healthbyjames/status/1620023652069810176?s=12&amp;t=s4vxK6BaKwF7YpJGclvpAg

bullish

$OCGN as scouser would say ABSOLUTELY BULLISH 😎

$OCGN bullish, what to expect moving forward for ocgn https://www.reddit.com/r/shortsqueeze2023/comments/11ntw73/what_to_expect_for_ocgn_going_into_marchapril_of/

sign

$OCGN I like the silence, usually a good sign

Sign up today and start receiving expert insights on potential market opportunities 
 
📈FREE trade-of-week via(Google Search) :⟶  𝐟𝐫𝐞𝐞𝐚𝐥𝐞𝐫𝐭.𝐩𝐰

Steady and strong, it charges ahead, 
A sign of growth and prosperity, no need to be misled.

BLUE

Bluebird bio Inc

-31.24%

$6.69 - $4.60

Oct, 6, 2022

ACRX

Acelrx Pharmaceuticals Inc

-66.25%

$2.03 - $0.69

Jan, 18, 2023

Jan, 10, 2023

OCGN

Ocugen Inc

-23.15%

$1.24 - $0.95

Nov, 20, 2022

Oct, 11, 2022

BLUE

Bluebird bio Inc

-31.24%

$6.69 - $4.60

Oct, 6, 2022

ACRX

Acelrx Pharmaceuticals Inc

-66.25%

$2.03 - $0.69

Jan, 18, 2023

Jan, 10, 2023

Jan, 4, 2023

Dec, 6, 2022

Dec, 2, 2022

Nov, 30, 2022

Nov, 28, 2022

Nov, 22, 2022

Nov, 21, 2022

Nov, 21, 2022

OCGN

Ocugen Inc

-23.15%

$1.24 - $0.95

Nov, 20, 2022

Oct, 11, 2022